Hcg hormone support for frozen embryo transfer in overweight women
Treatments studied
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study tests whether adding a hormone called HCG (human chorionic gonadotropin, the pregnancy hormone) to standard luteal support improves the chances of pregnancy after a frozen embryo transfer in women who are overweight. It may help the uterus stay ready for implantation in natural or ovulation-induced cycles.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 37 years old or younger.
- Your body mass index (BMI) is 24 or more, which is considered overweight for Asian populations.
- You are having a single frozen embryo transferred in a natural or light ovulation-stimulation cycle.
- You have at least one frozen embryo (from IVF or ICSI) that is at least 4BC quality and was frozen on day 5 or day 6.
- You do not have certain uterine conditions (like adenomyosis, hydrosalpinx, uterine adhesions, or untreated fibroids) and no history of immune disorders like lupus or antiphospholipid syndrome.
- You have not had two or more embryo transfers without a successful pregnancy (live birth).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving hCG before transferring a thawed embryo can improve success. It is for women who have at least one frozen embryo of good quality and are planning a frozen embryo transfer.
This trial checks if taking extra hormones after a frozen embryo transfer (called luteal support) is needed when using your natural cycle. It may help improve pregnancy chances.
This study compares two different ways to prepare the womb for transferring a frozen embryo, to see which approach works better. It aims to find the most effective method to help you have a successful pregnancy.
This trial tests whether giving a medication called a GnRH agonist (which affects hormones) before a frozen embryo transfer can improve the chances of pregnancy in women with infertility. It aims to see if this treatment helps the uterus accept the embryo better.
This Phase 3 study tests whether adding micronized progesterone during frozen embryo transfer cycles helps support embryo implantation and pregnancy. You may benefit if your care team is already preparing the uterus with hormone therapy for a blastocyst transfer.
This study tests a fertility medication (human menopausal gonadotropin) to see how well it helps women have a live birth after IVF with frozen embryos. It compares the medication's effectiveness for women with infertility who are planning to freeze all embryos and transfer them later.
Hear when a new Obesity, Maternal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.